Zhang Y, Liu W, Xu Y
Front Neurol. 2024; 15:1471736.
PMID: 39703359
PMC: 11655326.
DOI: 10.3389/fneur.2024.1471736.
Ran Z, Mu B, Wang D, Xin-Huang , Ma Q, Lu M
Mol Neurobiol. 2024; 62(4):5273-5296.
PMID: 39531191
DOI: 10.1007/s12035-024-04584-9.
Mandolfo O, Parker H, Aguado E, Learmonth Y, Liao A, OLeary C
EMBO Mol Med. 2024; 16(7):1579-1602.
PMID: 38890537
PMC: 11251277.
DOI: 10.1038/s44321-024-00092-4.
Zhang H, Xie J, Peng H, Lin Y, Song J
PLoS One. 2024; 19(5):e0302383.
PMID: 38713724
PMC: 11075903.
DOI: 10.1371/journal.pone.0302383.
An D, Xu Y
Heliyon. 2024; 10(9):e30175.
PMID: 38707435
PMC: 11068646.
DOI: 10.1016/j.heliyon.2024.e30175.
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
Saponjic J, Mejias R, Nikolovski N, Dragic M, Canak A, Papoutsopoulou S
Int J Mol Sci. 2024; 25(8).
PMID: 38673915
PMC: 11050170.
DOI: 10.3390/ijms25084330.
Exploring the causal relationship between B lymphocytes and Parkinson's disease: a bidirectional, two-sample Mendelian randomization study.
Song J, Qin Y, Wang L, Quan W, Xu J, Li J
Sci Rep. 2024; 14(1):2783.
PMID: 38307922
PMC: 10837417.
DOI: 10.1038/s41598-024-53287-7.
, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them?.
De Francesco M
Viruses. 2024; 16(1).
PMID: 38257833
PMC: 10818483.
DOI: 10.3390/v16010133.
Rehabilitation for non-motor symptoms for patients with Parkinson's disease from an α-synuclein perspective: a narrative review.
Liu Z, Lemus J, Smirnova I, Liu W
Explor Neuroprotective Ther. 2023; 3(4):235-257.
PMID: 37920444
PMC: 10621781.
DOI: 10.37349/ent.2023.00049.
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond.
Garmendia J, De Sanctis C, Das V, Annadurai N, Hajduch M, De Sanctis J
Curr Neuropharmacol. 2023; 22(6):1080-1109.
PMID: 37898823
PMC: 10964103.
DOI: 10.2174/1570159X22666231017141636.
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions.
Jimenez-Jimenez F, Alonso-Navarro H, Garcia-Martin E, Santos-Garcia D, Martinez-Valbuena I, Agundez J
Biomolecules. 2023; 13(8).
PMID: 37627328
PMC: 10452242.
DOI: 10.3390/biom13081263.
High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer's and Parkinson's disease.
Emery D, Davies M, Cerajewska T, Taylor J, Hazell M, Paterson A
Front Aging Neurosci. 2022; 14:1026260.
PMID: 36570533
PMC: 9780557.
DOI: 10.3389/fnagi.2022.1026260.
Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
Mysiris D, Vavougios G, Karamichali E, Papoutsopoulou S, Stavrou V, Papayianni E
Int J Mol Sci. 2022; 23(17).
PMID: 36077138
PMC: 9456372.
DOI: 10.3390/ijms23179739.
Viruses, parkinsonism and Parkinson's disease: the past, present and future.
Leta V, Urso D, Batzu L, Lau Y, Mathew D, Boura I
J Neural Transm (Vienna). 2022; 129(9):1119-1132.
PMID: 36036863
PMC: 9422946.
DOI: 10.1007/s00702-022-02536-y.
Sophoridine Suppresses Herpes Simplex Virus Type 1 Infection by Blocking the Activation of Cellular PI3K/Akt and p38 MAPK Pathways.
Tang Q, Luan F, Yuan A, Sun J, Rao Z, Wang B
Front Microbiol. 2022; 13:872505.
PMID: 35756044
PMC: 9229184.
DOI: 10.3389/fmicb.2022.872505.
Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.
Bao J, Chang W, Zhao Y
J Mol Neurosci. 2022; 72(9):1809-1819.
PMID: 35731466
DOI: 10.1007/s12031-022-02043-5.
Epidemiological Evidence for an Immune Component of Parkinson's Disease.
Gonzalez-Latapi P, Marras C
J Parkinsons Dis. 2022; 12(s1):S29-S43.
PMID: 35661019
PMC: 9535552.
DOI: 10.3233/JPD-223180.
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.
Kocurova G, Ricny J, Ovsepian S
Theranostics. 2022; 12(7):3045-3056.
PMID: 35547759
PMC: 9065204.
DOI: 10.7150/thno.72126.
Inflammation and immune dysfunction in Parkinson disease.
Tansey M, Wallings R, Houser M, Herrick M, Keating C, Joers V
Nat Rev Immunol. 2022; 22(11):657-673.
PMID: 35246670
PMC: 8895080.
DOI: 10.1038/s41577-022-00684-6.
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?.
Krey L, Huber M, Hoglinger G, Wegner F
Brain Sci. 2021; 11(12).
PMID: 34942956
PMC: 8699589.
DOI: 10.3390/brainsci11121654.